Bifogade filer
Kurs & Likviditet
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Bioteknik |
Oslo, 7 March 2022: Reference is made to the announcement made by Targovax ASA ("Targovax" or the "Company") 28 February 2022 regarding the appointment of Lubor Gaal as the new CFO of the Company.
The Board of Directors has resolved to grant 300,000 share options in the Company under the Company's long term incentive program, each with a strike price of NOK 1.53, to Lubor Gaal.
Following the grant of the 300,000 share options referred to above, Lubor Gaal holds nil shares and 300,000 options in the Company.
The options are granted without consideration. Pursuant to the vesting schedule, 25% of the options will vest 12 months after the day of grant (as long as the option holder is entitled to be part of the option program). Thereafter, 1/36 of the remaining options will vest each month as long as the option holder is entitled to be part of the option program, with the first 1/36 vesting 13 months after the day of grant. The exercise price is equal to the volume weighted average trading price of the shares of the Company on Oslo Børs on the date of the grant. Options that have not been exercised will lapse 7 years after the date of grant.
Please see the attached the notification of trading pertaining to the abovementioned mandatory notification of trade by primary insider.
Notification by Primary Insiders_Gaal_Mar21.pdf (https://mb.cision.com/Public/17093/3520223/ad13d8567bce2376.pdf)